Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

(*) mandatory field


Other search option(s)

Cholestasis-lymphedema syndrome

Orpha number ORPHA1414
Synonym(s) Aagenaes syndrome
Prevalence <1 / 1 000 000
Inheritance Autosomal recessive
Age of onset Infancy
  • Q82.0
MeSH -
MedDRA -


Cholestasis-lymphedema syndrome (CLS) is characterized by chronic severe lymphoedema and severe neonatal cholestasis that usually lessens during early childhood and becomes episodic. It has been described in six large families, mainly from Norway. The common feature of this autosomal recessive condition is a generalised lymphatic anomaly. This appears to indicate that the defect resides in lymphangiogenesis, but the genetic cause remains unknown. A genome screen has been performed using DNA from Norwegian patients. Affected individuals manifested extensive allele and haplotype sharing over the 6.6-cM D15S979-D15S652 region. All Norwegian patients with CLS are likely to be homozygous for the same disease mutation, inherited from a shared ancestor. The prognosis is variable: some patients died in early childhood (mainly of bleeding because of vitamin K deficiency), whereas others died of cirrhosis in later childhood and one woman died at the age of 50 years. In contrast, nine of the reported patients are still alive at ages ranging from 30 to 61 years.

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.

Captcha image
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.